Investment firm Baring Private Equity Asia is considering a takeover of medical laser company Lumenis in a deal that could be worth more than $1 billion, according to a report by Bloomberg News. The report is the latest news swirling about Lumenis, which was sold to the Hong-Kong-based XIO group in 2015 for approximately $510 […]
Report: Asian PE player eyes Lumenis for $1B
Another private equity firm, this time out of Asia, is said to be in the running for a $1 billion takeover of Israeli medical laser maker Lumenis. In 2018 another PE shop, CVC Capital Partners, was reportedly mulling a $900 million takeover of Lumenis, which was sold to the Hong-Kong-based XIO group in 2015 for about […]
Report: PE firm CVC in talks to acquire Lumenis in deal worth up to $900m
Private equity firm CVC Capital Partners is considering a take over of medical laser company Lumenis in a deal that could be worth up to $900 million, according to a report from CTech. The two parties are reportedly in advanced negotiations that would put the Israel-based medical and cosmetic laser biz under new ownership. Lumenis […]
Lumenis’ XIO buyout closes
Lumenis said it completed its $510 million take over by Hong-Kong based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. Shareholders will receive a […]
Lumenis shareholders approve $510m XIO take over
Lumenis shareholders approved the company’s $510 million sale to Hong Kong-based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. In June, Lumenis […]
Hong Kong’s Xio to pay $510m for Lumenis
Lumenis (NSDQ:LMNS) said today that it agreed to a $510 million acquisition bid from a Hong Kong-based “alternative investments” shop. Yokneam, Israel-based Lumenis, which raised $75 million in an initial public offering last year, was said in February to be in talks about a buyout by Chinese conglomerate Fosun for nearly $500 million. Today Lumenis said Xio Group put […]
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Lumenis in talks to be acquired by Fosun for $480M
Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.
Lumenis undercuts IPO price at $12 per share, shares gain nearly 9%
Lumenis Ltd. today priced its initial public offering at $12 per share, 20% under the low end of the prior $15-$17 range set by the Israeli maker of medical lasers.
Lumenis shares, trading under the "LMNS" symbol on the NASDAQ exchange, opened up 4.2% at $12.50 today and were fetching $13.05 apiece as of about 11:20 a.m., up 8.8%.
Lumenis sets $100M IPO terms
Lumenis Ltd. said it plans to sell 6.25 million shares at $15 to $17 apiece in its upcoming initial public offering.
That would bring in between $93.8 million and $106.3 million for the Israeli medical laser maker, which announced the IPO late last year.
Lumenis files for $115M IPO
Lumenis Ltd., an Israeli medtech company that makes lasers used in eye surgery, urology and cosmetic medical procedures, filed today for an initial public offering worth $115 million.
Yokneam, Israel-based Lumenis said it plans to trade on the NASDAQ stock exchange under the "LMNS" symbol.
